Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice

Generated: November 12, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 089081

« Back to Dashboard

NDA 089081 describes PRELONE, which is a drug marketed by Muro and Teva and is included in two NDAs. It is available from two suppliers. Additional details are available on the PRELONE profile page.

The generic ingredient in PRELONE is prednisolone. There are eighty-eight drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the prednisolone profile page.
Summary for 089081
Formulation / Manufacturing:see details
Pharmacology for NDA: 089081
Medical Subject Heading (MeSH) Categories for 089081
Suppliers and Packaging for NDA: 089081
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PRELONE prednisolone SYRUP;ORAL 089081 ANDA Aidarex Pharmaceuticals LLC 33261-475 33261-475-01 240 mL in 1 BOTTLE, PLASTIC (33261-475-01)
PRELONE prednisolone SYRUP;ORAL 089081 ANDA MedVantx, Inc. 66116-603 66116-603-24 240 mL in 1 BOTTLE (66116-603-24)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SYRUP;ORALStrength15MG/5ML
Approval Date:Feb 4, 1986TE:AARLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.